Biocomposites to host Infection Management Symposium on new best practice framework for treating diabetic foot infections at Wounds UK
- Consensus group of clinicians have developed a framework of best practice and toolkit for podiatrists treating diabetic foot infections
- STIMULAN placed in foot wounds following debridement can release antibiotics at therapeutic concentrations
Keele, UK, 3 November 2022 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, today announces that it will be hosting a symposium at this year’s Wounds UK Annual Conference to be held at the Harrogate Convention Centre, UK on 7-9 November 2022.
